bf/NASDAQ:TLSA_icon.jpeg

NASDAQ:TLSA

Tiziana Life Sciences Ltd

  • Stock

USD

Last Close

1.08

30/08 20:00

Market Cap

86.59M

Beta: -

Volume Today

688.32K

Avg: 151.75K

PE Ratio

−3.20

PFCF: −2.62

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
282.47K
-
-2.37M
939.40%
-5.65M
138.23%
average payables
334.15K
-
755.80K
126.18%
1.08M
43.44%
1.62M
49.81%
3.45M
112.17%
5.56M
61.42%
6.37M
14.49%
4.86M
23.68%
3.88M
20.11%
4.68M
20.62%
average receivables
1.89M
-
4.54M
140.43%
5.65M
24.33%
book value per share
-0.00
-
0.02
27,575.01%
0.03
14.16%
0.01
68.36%
-0.01
197.85%
0.00
147.82%
0.42
-
0.19
54.27%
capex per share
-0.00
-
-0.00
94.49%
-0.00
-
capex to depreciation
-4.38
-
-0.09
97.92%
-0.02
-
-1.39
9,102.82%
-0.16
88.81%
capex to operating cash flow
0.01
-
0.00
97.51%
0.00
-
0.01
1,790.13%
0.00
90.51%
capex to revenue
cash per share
0.00
-
0.03
67,205.35%
0.03
6.28%
0.01
57.11%
0.00
98.03%
0.04
16,891.10%
0.43
-
0.18
58.56%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
1.83
-
0.08
95.41%
0.02
72.11%
0.04
90.76%
0.13
186.89%
0.04
64.83%
0.34
666.72%
0.01
97.72%
0.01
-
debt to equity
-1.58
-
0.12
107.36%
0.03
78.09%
0.07
167.30%
-0.14
304.79%
0.59
527.52%
-0.15
125.07%
0.01
105.97%
0.02
-
dividend yield
earnings yield
-0.00
-
-0.04
26,139.81%
-0.02
44.38%
-0.01
43.48%
-0.03
100.29%
-0.05
81.99%
-0.25
-
-0.27
6.82%
enterprise value
2.75B
-
119.61M
95.66%
504.06M
321.42%
630.46M
25.07%
326.91M
48.15%
144.27M
55.87%
616.25K
99.57%
-65.16M
10,673.12%
51.83M
179.54%
43.16M
16.73%
enterprise value over ebitda
-5.78K
-
-29.77
99.48%
-39.50
32.66%
-70.19
77.70%
-29.37
58.15%
-15.30
47.93%
-0.06
99.59%
2.03
3,364.94%
-1.97
197.15%
-2.81
42.99%
ev to operating cash flow
-16.53K
-
-35.27
99.79%
-61.75
75.09%
-100.00
61.94%
-41.34
58.66%
-33.31
19.41%
-0.09
99.74%
5.14
5,926.36%
-2.38
146.31%
-2.20
7.61%
ev to sales
917.71K
-
free cash flow per share
-0.00
-
-0.03
48,601.14%
-0.02
39.68%
-0.01
24.19%
-0.03
119.20%
-0.03
14.18%
-0.22
-
-0.19
13.14%
free cash flow yield
-0.00
-
-0.03
45,543.17%
-0.02
42.81%
-0.01
36.79%
-0.02
142.60%
-0.03
19.84%
-0.23
-
-0.32
38.97%
graham net net
-0.00
-
0.02
18,331.74%
0.03
22.92%
0.01
70.48%
-0.02
325.17%
-0.01
51.41%
0.37
-
0.13
65.90%
graham number
0.00
-
0.16
27,635.17%
0.13
18.17%
0.06
53.69%
0.08
33.08%
0.07
8.94%
1.51
-
0.83
44.74%
income quality
1.31
-
0.61
53.47%
0.64
4.58%
0.71
11.06%
0.71
0.00%
0.46
35.41%
0.68
48.23%
0.42
37.92%
0.82
93.77%
1.27
56.05%
intangibles to total assets
0
-
0
0
0
0
0
0
0.00
Infinity%
0.00
42.09%
0
100%
interest coverage
-14.26
-
-478.56
3,256.77%
-809.78
69.21%
-916.22
13.14%
-827.22
9.71%
-107.97
86.95%
-87.65
18.82%
-155.53
77.46%
-2.08K
1,239.72%
interest debt per share
0.00
-
0.01
4,218.45%
0.00
87.31%
0.00
18.81%
0.00
100.10%
0.00
104.12%
0.00
-
0.00
103.88%
inventory turnover
invested capital
-1.58
-
0.12
107.36%
0.03
78.09%
0.07
167.30%
-0.14
304.79%
0.59
527.52%
-0.15
125.07%
0.01
105.97%
0.02
-
market cap
2.75B
-
122.82M
95.54%
516.93M
320.89%
635.98M
23.03%
326.66M
48.64%
149.24M
54.31%
94.01M
-
60.92M
35.21%
net current asset value
-240.75K
-
2.77M
1,248.83%
12.60M
355.51%
4.05M
67.82%
-2.30M
156.70%
513.91K
122.36%
-6.35M
1,335.88%
61.80M
1,073.07%
41.13M
33.44%
17.38M
57.76%
net debt to ebitda
-0.58
-
0.80
236.49%
1.01
26.35%
0.62
39.01%
-0.02
103.67%
0.53
2,435.34%
-0.06
111.76%
2.03
3,364.94%
1.60
20.93%
1.16
27.72%
net income per share
-0.00
-
-0.05
27,897.80%
-0.03
41.34%
-0.02
32.20%
-0.03
80.98%
-0.06
73.40%
-0.24
-
-0.16
33.24%
operating cash flow per share
-0.00
-
-0.03
48,601.14%
-0.02
39.68%
-0.01
24.70%
-0.03
120.67%
-0.03
14.20%
-0.22
-
-0.19
13.06%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-2.25
-
-1.43
36.47%
-0.93
34.60%
-1.43
52.92%
-3.70
159.10%
-1.10
70.17%
-4.04
266.41%
-0.39
90.25%
-0.48
22.11%
-0.61
27.30%
revenue per share
0.00
-
roe
1.94
-
-1.98
201.90%
-1.02
48.61%
-2.18
114.28%
4.02
284.94%
-14.59
462.61%
1.75
111.98%
-0.45
125.47%
-0.57
27.43%
-0.83
45.99%
roic
-3.37
-
-1.65
50.91%
-0.99
40.28%
-2.03
105.93%
4.67
329.43%
-9.14
295.78%
2.47
127.00%
-0.43
117.53%
-0.58
34.67%
-0.76
29.84%
sales general and administrative to revenue
157.20
-
shareholders equity per share
-0.00
-
0.02
27,575.01%
0.03
14.16%
0.01
68.36%
-0.01
197.85%
0.00
147.82%
0.42
-
0.19
54.27%
stock based compensation to revenue
11.54
-
tangible asset value
-240.75K
-
2.77M
1,248.83%
12.60M
355.51%
4.09M
67.55%
-2.27M
155.63%
521.52K
122.93%
-5.48M
1,150.90%
62.16M
1,234.19%
41.15M
33.80%
19.57M
52.44%
tangible book value per share
-0.00
-
0.02
27,575.01%
0.03
14.16%
0.01
68.36%
-0.01
197.85%
0.00
147.82%
0.42
-
0.19
54.12%
working capital
-240.75K
-
2.77M
1,248.83%
12.60M
355.51%
4.05M
67.82%
-2.30M
156.70%
513.91K
122.36%
-5.81M
1,231.02%
62.09M
1,168.26%
41.13M
33.75%
17.62M
57.17%

All numbers in USD (except ratios and percentages)